Ming Chen

Department of Pharmacology and Therapeutics, University of South Florida, College of Medicine, Tampa, Florida 3361 and Medical Research Service (151), Bay Pines VA Medical Center, St. Petersburg, Florida 33744

Received 4/27/98 Accepted 5/1/98

5. REFERENCES

1. Selkoe, D. J. Amyloid beta-protein and the genetics of Alzheimer's disease. J Biol Chem 271, 18295-18298 (1996)

2. Cordell, B. beta-Amyloid formation as a potential therapeutic target for Alzheimer's disease. Ann Rev Pharmacol Toxicol 34, 69-89 (1994)

3. Yankner, B. A. Mechanisms of neuronal degeneration in Alzheimer's disease. Neuron 16, 921-932 (1996)

4. Goedert, M. Tau protein and the neurofibrillary pathology of Alzheimer's disease. Trends Neurosci 16, 160-165 (1993).

5. Chen, M. Alzheimer's a -secretase may be a calcium-dependent protease. FEBS Lett 417, 163-167 (1997)

6. Lannfelt, L. Basun, H. Wahlund, L-O. Rowe, B. A. and Wagner, S. L. Decreased a -secretase-cleaved amyloid precursor protein as a diagnostic marker for Alzheimer's disease. Nature Med 1, 829-832 (1995)

7. Disterhoft, J. F. Gispen, W. E. Traber, J. and Khachaturian, Z. S. Eds: Calcium hypothesis of aging and dementia. Ann N Y Acad Sci vol.747, New York (1994)

8. Müller, W. E, Gispen, W. Eds: Current status of the calcium hypothesis of brain aging and Alzheimer's disease. Life Sci vol.59, Amsterdam (1996)

9. Trojanowski, J. Q. and Lee, V. M-Y. Phosphorylation of paired helical filament tau in Alzheimer's disease neurofibrillary lesion: focusing on phosphatases. FASEB J 9:1570-1576 (1995)

10. Gong, C. X. Singh, T. J. Grundke-Iqbal, I. and Iqbal. K. Alzheimer's disease abnormally phosphorylated tau is dephosphorylated by protein phosphatase-2B (calcineurin). J Neurochem 62, 803-806 (1994)

11. Chen, M. Is Alzheimer's disease associated with a decreased intracellular level of calcium? Front Biosci 3:let1-2 (1998) URL: http:/www.bioscience.org/v3/let/chen/list.htm

PubMed#: 9535645

12. Nixon, R. A. Calcium-activated neutral proteinases as regulators of cellular function. Implications for Alzheimer's disease pathogenesis. Ann N Y Acad Sci 568, 198-208 (1989)

13. Suzuki, K. Sorimachi, H. Yoshizawa, T. Kinbara, K. and Ishiura, S. Calpain: novel family members, activation, and physiologic function. Biol Chem Hoppe-Seyler 376, 523-529 (1995)

14. Litersky, J. M. and Johnson, G. V. Phosphorylation of tau in situ: inhibition of calcium- dependent proteolysis. J Neurochem 65, 903-911 (1992)

15. Pontremoli, S. Melloni, E. Michetti, M. Sparatore, B. Salamino, F. Sacco, O. and Horecker, B. L. Phosphorylation by protein kinases C of a 20-KDa cytoskeletal polypeptide enhances its susceptibility to digestion by calpain. Proc Natl Acad Sci USA 84, 398-401 (1987)

16. Chen, M. Regulation of platelet cytoskeleton: A phosphorylation-dephosphorylation mechanism. Thesis. State University of New York (1989)

17. Chen, M. and Stracher, A. In situ phosphorylation of platelet actin-binding protein by cAMP-dependent protein kinase stabilizes it against proteolysis by calpain. J Biol Chem 264, 14282-14289 (1989)

18. Kandel, E. R. and Schwartz, J. H. Principles of Neural Science, 3rd edn. Simon & Schuester Co. New York (1991)

19. Lynch, G. and Baudry, M. Brain spectrin, calpain and long-term changes in synaptic efficacy. Brain Res Bull 18, 809-815 (1987)

20. Yakel, J. L. Calcineurin regulation of synaptic function: from ion channels to transmitter release and gene transcription. Trends Pharmacol Sci 18, 124-134 (1997)

21. Tang, M. X. Jacobs, D. Stern, Y. Marder, P. Schofield, B. and Gurland, H. Effect of estrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet 348, 429- 432 (1996)

22. Arneric, S. P. Sullivan, J. P. Decker, M. W. Brioni, J. D. Bannon, A. W. Briggs, C. A. Donnelly-Roberts, D. Radek, R. J. Marsh, K. C. and Kyncl, J. Potential treatment of Alzheimer disease using cholinergic channel activators (ChCAs) with cognitive enhancement, anxiolytic-like, and cytoprotective properties. Alzheimer Dis. Assoc. Disorders (9 Suppl) 2, 50-61 (1995)

23. McGeer, P. L. and McGeer, E. G. Anti-inflammatory drugs in the fight against Alzheimer's disease. Ann N Y Acad Sci 777, 213-220 (1996)

24. Stephenson, J. More evidence links NSAID, estrogen use with reduced Alzheimer risk. JAMA 275, 1389-1390 (1996)

25. Morley, P. Whitfield, J. F. Vanderhyden, B. C. Tsang, B. K. and Schwartz, J. L. A new, nongenomic estrogen action: the rapid release of intracellular calcium. Endocrinol 131, 1305-1312 (1992)

26. Gray, R. Rajan, A. S. Radcliffe, K. A. Yakehiro, M. and Dani, J. A. Hippocampal synaptic transmission enhanced by low concentrations of nicotine. Nature 383, 713-716 (1996)

27. Fiorucci, S. Santucci, L. Gresele, P. Luinetti, O. and Morelli, A. Effect of NSAIDs on pepsinogen secretion and calcium mobilization in isolated chief cells. Am J Physiol 268, G968-978 (1995)

28. Flescher, E. Fossum, D. Gray, P. J. Fernandes, G. Harper, M. J. and Talal, N. Aspirin-like drugs prime human T cells. Modulation of intracellular calcium concentrations. J Immunol 146, 2553-2559 (1991)

29. Flescher, E. Ledbetter, J, A. Ogawa, N. Vela-Roch, N. Fossum, D. Dang, H. and Talal, N. Induction of transcription factors in human T lymphocytes by aspirin-like drugs. Cellular Immunol 160, 232-239 (1995)

30. Schmage, N. and Bergener, M. Global rating, symptoms, behavior, and cognitive performance as indicators of efficacy in clinical studies with nimodipine in elderly patients with cognitive impairment syndromes. Intl Psychogeriatrics (4 Suppl) 1, 89-99 (1992)

31. Saito, K-I. Elce, J. S. Hamos, J. E. and Nixon, R. A. Widespread activation of calcium- activated neutral proteinase (calpain) in the brain in Alzheimer disease: a potential molecular basis for neuronal degeneration. Proc Natl Acad Sci USA 90, 2628-2632 (1993)

32. Hyman, B.T. Van Hoesen, G. W. and Damasio, A. R. Alzheimer's disease: glutamate depletion in the hippocampal perforant pathway zone. Ann Neurol 22, 37-40 (1987)

33. Lamberts, S. W. van den Beld, A. W. and van der Lely, A-J. The endocrinology of aging. Science 278, 419-424 (1997)

34. Kristian, T. and Siesjo, B. K. Calcium-related damage in ischemia. Life Sci 59, 357-367 (1996)

35. Kim, S. H. Kim, Y. K. Jeong, S. J. Haass, C. Kim, Y. H. and Suh, Y. H. Enhanced release of secreted form of Alzheimer's amyloid precursor protein from PC12 cells by nicotine. Mol Pharmacol 52, 430-436 (1997)

36. Nitsch, R. M. Wurtman, R. J. and Growdon, J. H. Regulation of APP processing potential for the therapeutic reduction of brain amyloid burden. Ann N Y Acad Sci 777, 175-182 (1996)

37. Buxbaum, J. D. Ruefli, A. A. Parker, C. A. Cypess, A. M. and Greengard, P. Calcium regulates processing of the Alzheimer amyloid protein precursor in a protein kinase C- independent manner. Proc Natl Acad Sci USA 91, 4489-4493 (1994)

38. Levy-Lahad, E. Wasco, W. Poorkaj, P. Romano, D. M. Oshima, J. Pettingell, W. H. Yu, C. E. Jondro, P. D. Schmidt, S. D. Wang, K. Crowley, A. C. Fu, Y-H. Guenette, S. Y., Galas, D. Nemens, E. Wijsman, E. M. Bird, T. D. Schellenberg, G. D. and Tanzi, R. E. Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science 269, 973-977 (1995)

39. Sherrington, R. Rogaev, E. I. Liang, Y. Rogaeva, E. A. Levesque, G. Ikeda, M. Chi, H. Lin, C. Li, G. Holman, K. Tsyda, T. Mar, L. Foncin, J-F. Brunl, A. C. Montesi, M. P. Sorbi, S. Rainero, I. Pinessi, L. Nee, L. Chumakov, I. Pollen, D. Brookes, A. Sanseau, P. Polinsky, R. J. Wasco, W. Da Silva, H. A. R. Haines, J. L. Pericak-Vance, M. A. Tanzi, R. E. Roses, A. D. Fraser, P. E. Rommens, J. M. and St. Geoge-Hyslop, P. H. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 375, 754-760 (1995)

40. Hardy, J. New insights into the genetics of Alzheimer's disease. Ann Med 28, 255-58 (1996)

41. Müller, W. E. Hartmann, H. Eckert, A. Velbinger, K. and Forstl, H. Free intracellular calcium in aging and Alzheimer's disease. Ann N Y Acad Sci 786, 305-320 (1996)

42. Peterson, C. Ratan, R. Shelanski, M. Goldman, J. Changes in calcium homeostasis during aging and Alzheimer's disease. Ann N Y Acad Sci 568, 262-270 (1989)

43. Wong, P. C. Zheng, H. Chen, H. Becher, M. W., Sirinathsinghji, D. J. S. Trumbauer, M. E. Chen, H. Y. Price, D. L. Van der Ploeg, L. H. T. and Sisodia, S. S. Presenilin 1 is required for Notch1 and Dll1 expression in the paraxial mesoderm. Nature 387, 288-291 (1997)

44. Staubli, U. Larson, J. Thibault, O. Baudry, M. and Lynch, G. Chronic administration of a thiol-protease inhibitor blocks long-term potentiation of synaptic responses. Brain Res 444, 153-158 (1988)

45. Ivy, G. O. Protease inhibition causes some manifestations of aging and Alzheimer's disease in rodent and primate brain. Ann N Y Acad Sci 674, 89-102 (1992)